Physician Membership
Membership benefits:
Being a member of the Oregon Cancer Alliance keeps local and regional patients in our area. Most importantly, you will be part of delivering the highest level of coordinated care.
Oregon Cancer Alliance physicians:
- Provide ease of access for patients
- Become better known through reputation and marketing efforts
- Provide start-of-the-art clinical trials
- Collect data to support measures of quality outcomes to become a Center of Excellence
- Strengthen our collective position for reimbursement contracting
Current members
Charles K. Anderson, M.D.
Willamette Valley Cancer Institute and Research Center
Glenn S. Buchanan, M.D.
Willamette Valley Cancer Institute and Research Center
James E. Butrynski, M.D.
Willamette Valley Cancer Institute and Research Center
Benjamin L. Cho, M.D.
Willamette Valley Cancer Institute and Research Center
Nathan P. Christensen, M.D.
PeaceHealth Ear, Nose and Throat
Katelyn Clark, M.D.
NW Surgical Specialists
Daniel A. Cusati, M.D., F.A.C.S.
NW Surgical Specialists
Alex Dabrowiecki, M.D.
Radiology Associates, PC
David R. DeHaas, Jr., M.D., F.A.C.S.
NW Surgical Specialists
Ryan DeLee, MD
Eugene Gastroenterology Consultants
Emily Dunn, M.D.
Willamette Valley Cancer Institute and Research Center
Stacy Dunn, N.D., M.S.O.M., F.A.B.N.O.
Pacific Integrative Oncology
Miho Teruya Dougherty, M.D., M.P.H.
Willamette Valley Cancer Institute and Research Center
Jon Ekstrom, M.D.
Radiology Associates, PC
Kristian Ferry, M.D., F.A.C.S.
Avanté Surgical
Joseph A. Fiorillo, M.D.
Willamette Valley Cancer Institute and Research Center
John T. Fitzharris, M.D.
Willamette Valley Cancer Institute and Research Center
Luke Fletcher, M.D.
Willamette Valley Cancer Institute and Research Center
Donald Garbett, M.D.
Radiology Associates, PC
Audrey P. Garrett, M.D., M.P.H.
Willamette Valley Cancer Institute and Research Center
Jonathan Gonenne, M.D.
Eugene Gastroenterology Consultants
Winnie W. Henderson, M.D., Ph.D., F.A.C.S.
Oregon Surgical Wellness
Nichole K. Ingalls, M.D., M.P.H., F.A.C.S.
NW Surgical Specialists
Lauren Hammock, M.D.
Pathology Consultants, PC
Bernie Isuani, M.D.
Radiology Associates, PC
Peter S. Kay, M.D.
Eugene Gastroenterology Consultants
Christine F. Kollmorgen, M.D., F.A.C.S.
Oregon Surgical Wellness
Vipul Lakhani, M.D.
Oregon Medical Group
Lyle C. Lawnicki, M.D.
Pathology Consultants, PC
Haidy L. Lee, M.D.
Willamette Valley Cancer Institute and Research Center
Jae H. Lee, M.D.
Willamette Valley Cancer Institute and Research Center
Matthew Lonergan, M.D.
Willamette Valley Cancer Institute and Research Center
Denis M. McCarthy, M.D.
Pathology Consultants, PC
J. Robert McFarlane III, M.D.
Pathology Consultants, PC
Kenneth H. McCarley, M.D.
PeaceHealth Ear, Nose and Throat
Garth Meldrum, M.D.
Garth Meldrum Artistic Plastic Surgery
Michael Milstein, M.D.
Oregon Medical Group Radiologists
Kevin A. Modeste, M.B.B.S., F.A.C.S.
NW Surgical Specialists
Kiya Movassaghi, M.D., D.M.D.
Movassaghi Plastic Surgery
Diego Muilenburg, M.D.
Northwest Surgical Specialists
Claire Murphy, M.D.
Pathology Consultants, PC
Michele Neisley, N.D., M.S., F.A.B.N.O.
Pacific Integrative Oncology
Colin P. NewBill, M.D.
Pathology Consultants, PC
Brittany L. Pakalniskis
Pathology Consultants, PC
Misty M. Payne, M.D.
Pathology Consultants, PC
Jeff Sharman, M.D.
Willamette Valley Cancer Institute and Research Center
Marissa Simard, M.D.
Oregon Medical Group Radiologists
Jonathan T. Sims, M.D., M.B.A.
Radiology Associates, PC
Thomas C. Sroka, M.D., Ph.D.
Willamette Valley Cancer Institute and Research Center
Deven L. Smith, M.D.
Pathology Consultants, PC
Matthew Tommack, M.D.
Oregon Medical Group Radiologists
Marc Uemura, M.D., M.B.A.
Willamette Valley Cancer Institute and Research Center
Duc M. Vo, M.D., F.A.C.S.
NW Surgical Specialists
Bo Wang, M.D.
Willamette Valley Cancer Institute and Research Center
Merideth Wendland, M.D.
Willamette Valley Cancer Institute and Research Center
Kathleen Y. Yang, M.D.
Willamette Valley Cancer Institute and Research Center
Christopher Yasenchak, M.D.
Willamette Valley Cancer Institute and Research Center
Erik Young M.D., Ph.D.
Radiology Associates, PC
Dariusz Zawierucha, M.D.
Radiology Associates, PC
Membership requirements
- Must be nominated to the board by tumor-specific site leader
- Attend tumor-specific board at least 50% of the time
- Designate a navigator in the office to help with patient coordination
- Have electronic health records available to others in the tumor-specific group
- Follow NCCN and guidelines set by OCA
- Allow data collection to follow outcomes
- Document yearly CME in specified tumor type
- Pay quarterly fee
- Provide timely consultations: Urgent within 1 week, non-urgent within 2 weeks
Membership FAQs
1. How did the OCA start?
OCA started in 2012 when members of Willamette Valley Cancer Institute and Northwest Specialty Clinics came together to form an organization to have a more regional impact on cancer care, as well as improve communication and coordination with patient care.
2. Is membership limited to WVCI and NSC?
No. OCA is intended to bring together quality providers focused on disease specific cancer care. Membership is not limited to any organization affiliation.
3. If I am part of WVCI and NSC am I automatically a member of OCA?
No. To become a member a provider is required to be nominated by a disease team leader and be approved by the board. Each member needs to fulfill the membership requirements.
4. How much are dues?
Dues are $200 a quarter.
5. What if I cannot meet all the requirements of membership?
Rare exceptions will be made on a case-by-case basis by the Board.
6. What is considered a “navigator”?
Although some facilities have full-time navigators, a navigator can be a nurse, scheduler or physician assistant. They need to be available to coordinate care with other navigators in the system.
7. Am I responsible for the expense of others accessing my EHR?
No. Part of membership requires the ability of others in the disease-specific team to have access to each other’s EHR. Cost of access falls on the person wanting access. Typically these costs are not excessive.
8. My tumor type is not listed. Are you expecting to add other tumor types in the near future?
Yes. We are in the process of adding more.